Antibacterial Agents TRIZ Cases

Mesenchymal stem cells and secreted proteins treat corneal surface diseases by reducing inflammation and promoting healing.

CPZEN-45 overcomes extensive drug resistance in XDR-TB and MDR-TB strains through specific structural modifications.

ADCC competent anti-CD39 antibodies target suppressive cells in the tumor microenvironment to enhance T-cell infiltration.

Azabicycloalkane derivatives with specific substituents demonstrate affinity for nicotinic receptors, addressing insufficient binding in existing compounds.

Labiatae plant extracts eliminate Helicobacter pylori without antibiotic resistance risks, maintaining efficacy under heat stress.

Pure strain fermentation using Penicillium rubens stabilizes Mirabilitum Praeparatum quality while shortening the production cycle.

LNT113 fusion protein overcomes gram-negative outer membrane barriers by combining endolysin with Cecropin A for enhanced bactericidal activity.

A polyvinyl alcohol copolymer film coats metformin tablets to block chemical reactions with adjacent drugs.

A nano-sized palladium porphyrin complex enhances electron donation and cell penetration through para-positioned hydroxy groups.

Polyols stabilize rifaximin beta polymorphs by reducing water content below 4.5 percent through hydrogen bonding mechanisms.

Sphingosine derivatives activate endogenous phospholipase D in macrophages, enhancing bacterial degradation without triggering immune reactions.

Silicon-coated iron nanoparticles resolve the trade-off between high specific absorption rate values and aqueous stability for cancer therapy.

Extracellular vesicles from indoor air establish animal models for respiratory disease screening and vaccine development.

Specific substituent patterns on the hydroxypyrimidinone core enhance cell permeability and reduce off-target toxicity while maintaining LpxC inhibition.

Crystal forms I and II of bedaquiline fumarate exhibit improved physical stability and dissolution rates.

Engineered nanobodies stabilize unstable GPCR active states, enabling high-resolution crystallization despite conformational heterogeneity.

Sulfone exposure stabilizes rough Mycobacterium obuense morphology, preventing reversion to smooth variants and enabling reliable cellular immune modulation.

Amino acid substitutions in IL-2 muteins reduce regulatory T cell expansion while maintaining effector stimulation for improved cancer therapy.

Segmentation and parameter changes enhance Disorazole Z stability while maintaining antibiotic activity.

Modifying the chemical structure of 16-membered tylonolides overcomes antibiotic resistance mechanisms in Gram-positive and Gram-negative bacteria.

Formula I compounds merge isoniazid and rifampicin structures to treat multidrug-resistant tuberculosis without complex regimens.

Purified IgM protease subunit vaccine overcomes whole-cell bacterin failures to provide reliable protection against Streptococcus suis infections.

Inert atmosphere heating of hydroquinone and piperidine eliminates solvent evaporation and combustion risks while maintaining high yield.

Merging Wittig reaction, isomerization, and deprotection into a single pot eliminates intermediate isolation, boosting yield while maintaining purity.

Co-culturing probiotics with Bacillus subtilis generates a protective biofilm matrix that encapsulates beneficial bacteria.

Removing virulence genes from Histophilus somni prevents adverse side effects while maintaining vaccine reliability.

A fusion protein vaccine comprising N-terminal fragments of Rib and alpha proteins elicits protective immunity against Group B Streptococcus infections.

Polymeric matrices enable miconazole and ketoconazole to exhibit antineoplastic, antibacterial, and spermiostatic activities alongside antifungal effects.

Boronic acid derivatives act as potent beta-lactamase inhibitors to restore antibiotic efficacy against resistant bacterial strains.

Genome mining discovers cationic nonribosomal peptides that destroy multidrug-resistant Gram-negative bacteria while resisting resistance development.

Ultrasonic synthesis of doped metal oxide nanoparticles creates defect sites that produce reactive oxygen species, overcoming antibiotic resistance in biofilms.

Periplasmic targeting signal sequences redirect recombinant protein expression from the cytoplasm to the periplasm, preventing inclusion body formation.

Glycomimetic compounds bind PA-IL and PA-IIL lectins to block bacterial adhesion, preventing colonization without high antibiotic doses.

Assessing TCRβ CDR3 sequences identifies Borrelia burgdorferi infection markers, resolving poor diagnostic sensitivity in seronegative patients.

In vitro thymic differentiation using agonist peptide complexes selects TCRs with tenfold higher tumor antigen affinity while preserving specificity.

Fluorinated pyridine and pyrimidine compounds address understudied antimicrobial gaps by treating resistant strains like MRSA.

Fe(III), Ni(II), and Cu(II) H2AZD complexes achieve enhanced antimicrobial effectiveness through green synthesis using water and ethanol solvents.

A novel RIPK1 inhibitor compound designed to penetrate the blood-brain barrier and inhibit kinase activity.

Morpholin-4-yl-pyrazolo[4,3-b]pyridine derivatives block the ATR-CHK1 pathway to overcome chemotherapy resistance in p53-mutant cancers.

Solvent volatilization transforms unstable Form I into stable Form II, resolving hygroscopicity and low solubility bottlenecks.

Organic carboxylic acids and non-carboxylic reducing acids generate nitric oxide from nitrite salts alongside organic polyols.

Bacteriophage ΦCJ11 eliminates pathogenic Salmonella strains through specific viral infection, resolving antibiotic resistance risks in livestock management.

Heterocyclic C-ring substitution in oxazolidinone antibiotics improves activity against linezolid-resistant Gram-positive pathogens while reducing cytotoxicity.

AgrA antagonists bind the phosphoryl-binding pocket to inhibit virulence factor synthesis, reducing pathogenicity without affecting bacterial growth.

A non-thermal plasma system generates reactive species to inactivate pathogens in the oral cavity and respiratory tract.

Small molecule efflux pump inhibitors block bacterial extrusion mechanisms to restore antibiotic susceptibility in resistant strains.